A recent investigation79 indicated that exosome carrying Wnt agonist 1 could alleviate bone loss and promote bone formation in colitis mice, using exosome loaded with IRE1α agonist or antagonist to treat bone‐related disease may be beneficial to identify the accurate effect of IRE1α pathway on in vivo osteogenesis. This evidence concerns the gene ERN1 and colitis.